🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

ecDNAs can drive explosive increase in oncogene copy number that not only promote tumor growth but also adaptability in the face of therapeutics - Amazing Syndicate talk by Paul Mischel Stanford Medicine. Paradigm shifting! BasserBRCA Penn Center for Genome Integrity Boundless Bio

Thank you Charles Ishak from MD Anderson Cancer Center for an inspiring Syndicate talk on repetitive elements and their contribution to tumorigenesis! BasserBRCA Penn Center for Genome Integrity Ovarian Cancer Research Alliance Ovarcome Tina's Wish

Executive Director Susan Domchek, MD & Penn Medicine - Abramson Cancer Center's Director Robert Vonderheide, MD, DPhil at the Fellows of the 2025 AACR Academy Induction and Opening Ceremonies. Extraordinary scientists 🤝 remarkable work!

“It takes people volunteering to move research forward. And I’m very, very glad that I was able to be in the position to do that.” Ben Jarvis is 1 of 44 volunteers participating in the @basserbrca clinical trial that aims to stop cancer before it starts: spr.ly/6016NQJfa

#ASCO25 ASCO A phase Ib trial of DNA plasmid vaccine immunotherapy targeting BRCA1/2 mutations shows encouraging safety data. Dr. Susan Domchek w/ an oral presentation on June 2, 11:30 AM CDT, S100a (Abstract 10505). Cancer interception in action! BasserBRCA Penn Medicine - Abramson Cancer Center

Ovarian cancer takes too many lives and receives too little attention. We’re investing $5.25M in bold, interdisciplinary science to change that. The Pershing Square Ovarian Cancer Challenge Grant is supporting 7 world-class researchers to drive progress where it’s most urgently

Delighted and honored to receive this award from Pershing Square Philanthropies. We are very excited to push our work, led by Matt Knarr Matthew Knarr, on tumor innervation towards novel diagnostics and therapeutics for ovarian cancer. BasserBRCA Penn Medicine - Abramson Cancer Center Penn Medicine CSO Ovarian Cancer Academy

At #ASCO25 our Penn Medicine - Abramson Cancer Center BasserBRCA teams will be sharing updates on CAR T cell therapy for glioblastoma, cancer interception, and much more! Stephen Bagley DrORourke Charu Aggarwal, MD, MPH, FASCO spr.ly/6011NfSGz

A recent study from Kara Maxwell shed light on the genomic differences in metastatic #prostatecancer btwn non-Hispanic Black + non-Hispanic white veterans, revealing survival outcomes are similar when both groups have equal access to care: spr.ly/601246QTO

Experts shared some of the most talked-about abstracts and discussions from the 2025 AACR Annual Meeting, including Ronny Drapkin 🎗, Director of Gynecologic Cancer Research, on better understanding features of aggressive disease in early precancers: spr.ly/601546QQ3

Both the type and location of mutations in BRCA2 significantly contribute to variation in breast cancer risk, according Katherine Nathanson's population-based research. This study's findings will greatly inform risk estimates for women with BRCA2 mutations: spr.ly/601446vpK

Angela R. Bradbury, MD presented on Genetic Testing Approach in Patients With Metastatic Cancers at the 2025 ASCO Annual Meeting: spr.ly/601446vIC

Payal Deepak Shah, MD presented her findings during the 'Diving Deeper to Inform Hereditary Cancer Risk and Outcomes' poster session at the 2025 ASCO Annual Meeting. Her research focused on Pathogenic Germline Variants: Clinical Implications and Knowledge Gaps.

Dr. Susan Domchek is presented with the 2025 ASCO-American Cancer Society Cancer Prevention Award as a distinguished expert who has made significant contributions to cancer prevention and research. We’re honored to have her at the forefront of cancer prevention research!

Maliha Tayeb, BA, BS, research coordinator in Kara Maxwell and Heather Symecko, MPH, Basser executive director of administration, showcased their work during the Prevention, Risk Reduction, and Genetics poster session at the 2025 @ascocancer Annual Meeting.

For Maggie, volunteering her body to help advance cancer prevention research is an act of love. “I saw other patients talking about their experience with the clinical trial, and why they were doing it, and I realized, ‘I need to do this!’” Penn Medicine spr.ly/601446cF8

Congratulations to Ronny Drapkin 🎗 (Penn Medicine OBGYN Department), recipient of a 2025 Pershing Square Philanthropies Ovarian Cancer Challenge Grant! Penn Ovarian Cancer Research Center Penn Medicine - Abramson Cancer Center BasserBRCA tinyurl.com/yjvvyr4k

Researchers from Penn Vet, @pennmedicine, & Children's Hospital showed that modifying mRNA vaccines with a cytokine could make the benefits of vaccines last longer and offer a potential approach for reducing the risk of cancer. @Basserbrca funded this study. spr.ly/60184bHzQ

The Pershing Square Foundation—established by Giving Pledge signatory Bill Ackman—announced seven grants totaling $5.25 million in support of #ovariancancer research. Awardees include Ronny Drapkin 🎗, MD, PhD, @basserbrca director of Gynecologic Research: spr.ly/60134bH4z

Researchers suspect the reason why ovarian cancer often begins in the fallopian tube has to do with ovulation, shares Ronny Drapkin 🎗. Oncologists are trying to dispel the confusion between “tube-tying” and salpingectomy, which can prevent ovarian cancer: spr.ly/60104byFK